Conversely, the inhibitory role of FcγRIIB may be disadvantageous for tumor eradication; when engaged with antigen-bound IgG, FcγRIIB inhibits both antibody-dependent cellular cytotoxicity and phagocytosis [23]. This evidence concerns the gene FCGR2B and neoplasm.